GPR176 and ovarian cancer: Moreover, GPR176 knockdown has been found to impede the proliferation, glucose catabolism, anti-apoptotic and anti-pyroptotic properties, migration, invasion and epithelial-mesenchymal transition of breast cancer cells (Yun et al. 2023), which is in agreement with results obtained from ovarian cancer cells (Yang et al. 2023).